C79.60 Secondary malignant neoplasm of unspecified ovary

Name of the Condition

• Secondary Malignant Neoplasm of Unspecified Ovary
• ICD-10 Code: C79.60

Summary

Secondary malignant neoplasm of the unspecified ovary refers to cancer that has metastasized to the ovaries from a primary tumor located elsewhere in the body. This condition indicates the spread of an existing malignancy to the ovarian tissue and requires evaluation to identify the primary cancer source and guide management.

Causes

Secondary malignant neoplasms of the unspecified ovary arise when cancer cells from a primary tumor detach, travel through the bloodstream or lymphatic system, and establish new tumors in the ovaries. Common primary sites include the breast, gastrointestinal tract, or other organs with high metastatic potential.

Risk Factors

• History of primary cancer, particularly those with known ovarian metastatic patterns (e.g., breast, colorectal).
• Advanced stage of the primary tumor.
• Lack of effective treatment for the primary cancer.
• Weakened immune system.
• Genetic predisposition to aggressive cancer types.

Symptoms

• Abdominal or pelvic pain.
• Bloating or swelling in the abdomen.
• Changes in bowel or urinary habits.
• Unexplained weight loss or fatigue.
• Vaginal bleeding (postmenopausal or irregular).
• Palpable abdominal mass.

Diagnosis

Imaging tests (CT, MRI, or PET scans) are used to detect metastatic lesions in the ovaries. Biopsy of ovarian tissue confirms the presence of cancer cells and helps determine the primary tumor source. Laboratory tests may assess tumor markers or organ function.

Treatment Options

• Chemotherapy: Targets cancer cells throughout the body, including metastatic sites.
• Hormone therapy: May be used if the primary cancer is hormone-sensitive.
• Radiation therapy: Can relieve symptoms or target specific metastatic areas.
• Surgery: May be considered to remove localized metastases or manage complications.
• Targeted therapy: Focuses on specific molecular pathways involved in cancer growth.

Prognosis and Follow-Up

Prognosis depends on the primary cancer type, extent of metastasis, and response to treatment. Regular follow-up with imaging and clinical evaluations is essential to monitor for recurrence or progression. Treatment plans are tailored to the primary cancer and overall health status.

Complications

• Bowel obstruction or perforation.
• Ascites (fluid buildup in the abdomen).
• Ovarian torsion (rare).
• Metastasis to additional organs.
• Treatment-related side effects (e.g., nausea, fatigue, organ toxicity).

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support overall health.
• Avoid tobacco and limit alcohol consumption.
• Follow recommended cancer screening guidelines for primary tumor sites.
• Manage stress and prioritize mental health during treatment.

When to Seek Professional Help

Seek immediate medical attention for severe abdominal pain, unexplained weight loss, persistent bloating, or signs of infection (e.g., fever, chills). Regular follow-up with an oncologist is critical for monitoring and managing metastatic disease.

Tips for Medical Coders

Use C79.60 for secondary malignant neoplasms of the ovary when the primary site is unspecified. Document the absence of a specified primary cancer source and confirm the metastatic nature of the ovarian involvement. Ensure clinical documentation supports the diagnosis and aligns with coding guidelines for secondary neoplasms.